Mokhtari, R. B., Qorri, B., Baluch, N., Sparaneo, A., Fabrizio, F. P., Muscarella, L. A., . . . Yeger, H. (2021). Next-generation multimodality of nutrigenomic cancer therapy: Sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis. Oncotarget.
Citação norma ChicagoMokhtari, Reza Bayat, et al. "Next-generation Multimodality of Nutrigenomic Cancer Therapy: Sulforaphane in Combination With Acetazolamide Actively Target Bronchial Carcinoid Cancer in Disabling the PI3K/Akt/mTOR Survival Pathway and Inducing Apoptosis." Oncotarget 2021.
Citação norma MLAMokhtari, Reza Bayat, et al. "Next-generation Multimodality of Nutrigenomic Cancer Therapy: Sulforaphane in Combination With Acetazolamide Actively Target Bronchial Carcinoid Cancer in Disabling the PI3K/Akt/mTOR Survival Pathway and Inducing Apoptosis." Oncotarget 2021.